is the most common cause of chronic extensive pain in the United States and excessively
affects women. The U.S. Centers for Disease Control and Prevention estimates
that about 2 percent of the population—around 4 million adults—have
fibromyalgia. Other organizations approximate even higher numbers. Approximately
three in four people with fibromyalgia have not received a precise diagnosis,
according to previous research, and those who are familiar that they have fibromyalgia
spend an average of five years between symptom commencement and diagnosis.
Common symptoms include pain and stiffness all over the body, fatigue,
depression, fretfulness, sleep problems, headaches and problems with thinking,
memory and concentration.
Lab tests often appear typical in these patients. Doctors
must rely on patients’ symptoms, results from physical and objective exams and
the exclusion of other diseases to come to a fibromyalgia diagnosis focusing on
specific tender points. On the other hand, there’s no blood test – no
clear-cut, easy-to-use tool to endow with a quick answer. Experts estimate about 75 percent of fibromyalgia
cases are left undiagnosed mean while others live with pain for years and years,
often receiving treatment that are unproductive or even can be harmful for the
Ohio State University’s College of Medicine conducted
a new research that has potentially found a new way to
detect fibromyalgia with blood tests. The study’s authors caution
that more work is needed before a blood test based on their work can be created
but they are very optimistic about it.
could be an important decisive moment in care of patients with a disease that
is frequently misdiagnosed or left undiagnosed, leaving the patients devoid of
proper care and guidance on managing their unceasing pain and fatigue”, said
lead researcher Kevin Hackshaw, an
associate professor in Ohio State’s College
and a rheumatologist at the university’s Wexner Medical Center.
“We found clear reproducible metabolic patterns in the blood of dozens of
patients with fibromyalgia; this brings us closer to a blood test than we have
ever been.” Dr Hawkshaw said.
Like all chronic conditions, fibromyalgia is not
curable and its treatment is often hit and misses with patients being given antidepressants
and very strong addictive painkillers like opioids that never benefit them.
Research that was conducted by Dr. Hackshaw
published the results of their work in the Journal of Biological
Chemistry. The research examined 50 individuals with fibromyalgia disease, 29 of
them with rheumatoid arthritis, 19 people
with osteoarthritis and 23 of them with lupus.
then looked into the blood samples from every participant, measuring the energy
levels of molecules. They found that there were clear different patterns in the
blood of patients suffering from fibromyalgia that made them distinct from
those with the other disorders.
“Being able to see the biological variations within the blood of these with fibromyalgia
patients compared to those with alternative diseases
like lupus, osteoarthritis and rheumatoid arthritis finally gives patients
justification of their symptoms,” Hackshaw said.
“Not solely will this facilitate the direct treatment, however additionally prevents the employment of inessential medications, like opiates, that don’t ease fibromyalgia pain and can lead to severe addiction.” He further mentioned.
“Each person’s blood is unique, like a fingerprint, and this test can show us the intricate details of that fingerprint, we can look back into some of these fingerprints and potentially establish a number of the chemicals related to the variations we tend to see.” said Dr.Luis Rodriguez-Saona, author of the study and academic of food science and technology at Ohio State.
On top to identifying fibromyalgia through blood tests, the researchers also originate evidences that showed that the metabolic fingerprinting technique has also the potential to find out the sternness of fibromyalgia in an individual patient.